Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012 (2012), Article ID 497213, 8 pages
Research Article

Renal Inhibition of Heme Oxygenase-1 Increases Blood Pressure in Angiotensin II-Dependent Hypertension

1Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA
21st Department of Internal Medicine, Medical and Health Sciences Center, University of Debrecen, 4032 Debrecen, Hungary

Received 8 August 2011; Accepted 6 September 2011

Academic Editor: David Sacerdoti

Copyright © 2012 Eva Csongradi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • M. N. Rahman, D. Vukomanovic, J. Z. Vlahakis, W. A. Szarek, K. Nakatsu, and Z. Jia, “Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds,” Journal of The Royal Society Interface, vol. 10, no. 78, pp. 20120697–20120697, 2012. View at Publisher · View at Google Scholar
  • D. E. Stec, M. V. Storm, B. E. Pruett, and M. U. Gousset, “Antihypertensive Actions of Moderate Hyperbilirubinemia: Role of Superoxide Inhibition,” American Journal of Hypertension, vol. 26, no. 7, pp. 918–923, 2013. View at Publisher · View at Google Scholar
  • Pittalà, Salerno, Romeo, Modica, and Siracusa, “A focus on heme oxygenase-1 (HO-1) inhibitors,” Current Medicinal Chemistry, vol. 20, no. 30, pp. 3711–3732, 2013. View at Publisher · View at Google Scholar
  • Stefan W. Ryter, and Augustine M.K. Choi, “Targeting Heme Oxygenase-1/Carbon Monoxide for Therapeutic Modulation of Inflammation,” Translational Research, 2015. View at Publisher · View at Google Scholar
  • Geeta Negi D Ph., Vanaja Nakkina M.S. Pharm, Pallavi Kamble M.S. Pharm, and Shyam SSharma D Ph., “Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy,” Pharmacological Research, 2015. View at Publisher · View at Google Scholar
  • David E. Stec, Luis A. Juncos, and Joey P. Granger, “Renal Intramedullary Infusion of Tempol Normalizes the Blood Pressure Response to Intrarenal Blockade of Heme Oxygenase-1 in Angiotensin II-Dependent Hypertension,” Journal of the American Society of Hypertension, 2016. View at Publisher · View at Google Scholar
  • Maaike Hum, Brian E. McLaughlin, Xianqi Kong, Jason Z. Vlahakis, Dragic Vukomanovic, Walter A. Szarek, and Kanji Nakatsu, “Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole,” Canadian Journal of Physiology and Pharmacology, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Peter Hosick, Mary Weeks, Michael Hankins, Kyle Moore, and David Stec, “Sex-Dependent Effects of HO-1 Deletion from Adipocytes in Mice,” International Journal of Molecular Sciences, vol. 18, no. 3, pp. 611, 2017. View at Publisher · View at Google Scholar
  • Camila Eleuterio Rodrigues, José Manuel Condor Capcha, Ana Carolina de Bragança, Talita Rojas Sanches, Priscila Queiroz Gouveia, Patrícia Aparecida Ferreira de Oliveira, Denise Maria Avancini Costa Malheiros, Rildo Aparecido Volpini, Mirela Aparecida Rodrigues Santinho, Bárbara Amélia Aparecida Santana, Rodrigo do Tocantins Calado, Irene de Lourdes Noronha, and Lúcia Andrade, “Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury,” Stem Cell Research & Therapy, vol. 8, no. 1, 2017. View at Publisher · View at Google Scholar